U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07053852) titled 'Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage' on Feb. 05.
Brief Summary: To provide a treatment of both actinic keratoses and photodamage within one treatment.
Study Start Date: June 27
Study Type: INTERVENTIONAL
Condition:
Actinic Keratoses
Photodamage
Intervention:
DRUG: Ameluz
broad band light (BBL) with the use of Ameluz
DEVICE: Sciton HEROic
Each subject will receive 2 treatments of photodynamic therapy using Ameluz and HEROic BBL to treat facial AK and signs of photodamage.
Recruitment Status: RECRUITING
Sponsor: Sherrif Ibrahim
Information provided by (Responsible Part...